Barely Significant
← all excerpts

Phase I trial of TRC102 (methoxyamine HCl) in combination with temozolomide in patients with relapsed solid tumors and lymphomas.

Oncotarget · 2020 · PMC7646836 · PMID 33216844

Europe PMCDOI
1
hedged sentence
0.1000
closest p · 2.0× alpha
0.1000
boldest claim

The sentences

approached significancep= 0.10so close (0.05 < p ≤ 0.1)
All baseline biopsies were assessed for MGMT protein expression by IHC ( Figure 3A ) and no statistically significant relationship was established between MGMT expression and patient outcome; the most suggestive finding was that the relationship between low MGMT expression and stable disease approached significance by 2-sided Fisher’s Exact Test ( p= 0.10).

also in 8,237 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.